Verily Life Sciences Llc Patent Portfolio Statistics

Verily Life Sciences Llc

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Verily Life Sciences Llc look like?

Assignee Art Units
Total Applications: 902 1,893,548
Granted Patents: 693 1,116,805
Grant Index 92.52% 75.72%
Abandoned/Rejected Applications: 56 (7.48%) 358,199 (24.28%)
In-Process Applications: 150 418,544
Average Grant Time: 2.74 Years 2.7 Years
Average Office Actions: 1.74 1.58

Which Technology Area Verily Life Sciences Llc is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
2872 Optics 76
3792 Medical Instruments, Diagnostic Equipment, and Treatment Devices 57
3735 Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting 50
3791 Medical Instruments, Diagnostic Equipment, and Treatment Devices 50
Opap Parked GAU 41

How many patents are Verily Life Sciences Llc filing every year?

Year Total Applications Predicted
2022 0* 354
2021 26* 370
2020 69 344
2019 123 123
2018 151
2017 153
2016 79
2015 90
2014 91
2013 85

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Verily Life Sciences Llc in USPTO?

Publication number: None
Application number: 17/622,561

Abstract:


Publication date:
Applicant: Verily Life Sciences Llc
Inventors: Bo Lu


Publication number: US20220126106A1
Application number: 17/276,439

Abstract:
A stimulation system can include one or more stimulating components, each of which can include one or more electrodes and one or more leads. Each lead can be connected at a first end of the lead to an electrode of the one or more electrodes and can be connected at a second end of the lead to a bonding pad of the one or more bonding pads. The stimulation system can also include a cylindrical substrate. Each stimulating component can be secured to a surface of the cylindrical substrate. The stimulation system can further include a skull-mount package that includes electronics that identify stimulation parameters. The bonding pads can be electrically connected to the electronics. The skull-mount package can further include one or more bonding pads. Each lead can be directly electrically and physically connected to a bonding pad of the one or more bonding pads.

Publication date: 2022-04-28
Applicant: Verily Life Sciences Llc
Inventors: Annapurna Karicherla


Publication number: None
Application number: 17/610,657

Abstract:


Publication date:
Applicant: Verily Life Sciences Llc
Inventors: Sinha Supriyo


How are Verily Life Sciences Llc’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/622,561 Connectors For High Density Neural Interfaces Docketed New Case – Ready for Examination OPAP Central, Docket
17/276,439 Stimulation System With Monolithic-Lead Component Connected To Skull Mount Package Docketed New Case – Ready for Examination OPAP Central, Docket
17/610,657 Biofluid Shunt Valve With Sheath And Monitoring Device Docketed New Case – Ready for Examination OPAP Central, Docket
17/454,138 Shift Invariant Loss For Deep Learning Based Image Segmentation Docketed New Case – Ready for Examination OPAP Central, Docket
17/452,270 Detecting Events During A Surgery Docketed New Case – Ready for Examination OPAP Central, Docket